SMAD2 and breast cancer: Furthermore, reduced LPP levels do not influence breast cancer cell proliferation (Supplementary Fig. 2c,d) or signalling responses induced by TGFβ, including phosphorylation of Smad2 (Supplementary Fig. 2e,f).